COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
The Centers for Disease Control and Prevention (CDC) last week released guidance dropping its requirement for
White House health leaders stated this week the public likely will need annual COVID-19 booster shots,
The Food and Drug Administration (FDA) this week approved COVID-19 booster shots from Pfizer and Moderna targeting the omicron BA.4 and BA.5 subvariants
The Centers for Disease Control and Prevention (CDC) will resume control of COVID-19 hospital data collection in mid-December
Health care workers who received two or three vaccine doses were less likely to get long COVID-19 compared with unvaccinated health care workers, according to an observational study in Italy.
COVID-19 vaccinations began this week for children under the age of five.
Last week, the Food and Drug Administration (FDA) granted emergency use authorization for the first breathalyzer test designed to detect COVID-19 in adults.
Adults who received an initial Johnson & Johnson (J&J) COVID-19 vaccine should receive a Pfizer or Moderna booster at least two months later for the best protection
Federal officials at the Centers for Medicare and Medicaid Services and the Centers for Disease Control and Prevention called for a renewed focus on patient safety
Completion of a 2-dose mRNA COVID-19 vaccination series during pregnancy might help prevent COVID-19 hospitalization among infants